Showing results (31-40 of 124) with videos related to
Sort By:
Pageof 13
Pharmaceutical Biology|November 23, 2022
Curcuma longa and Boswellia serrata extract combination for hand osteoarthritis: an open-label pre-post trialYves Henrotin, Yvan Dierckxsens, Gaëlle Delisse, et al.Current Medical Research and Opinion|December 8, 2020
Curcuminoids and Boswellia serrata extracts combination decreases tendinopathy symptoms: findings from an open-label post-observational studyYves Henrotin, Yvan Dierckxsens, Gaëlle Delisse, et al.Joint Bone Spine|November 22, 2008
Osteoarthritis and obesity: experimental modelsOdile Gabay, David J Hall, Francis Berenbaum, et al.Joint Bone Spine|December 17, 2010
Is volition the missing link in the management of low back pain?Jean-Paul Broonen, Marc Marty, Valérie Legout, et al.Plos One|March 17, 2018
Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot studyChristelle Sanchez, Gabriel Mazzucchelli, Cécile Lambert, et al.Plos One|March 24, 2015
Curcuminoids extract, hydrolyzed collagen and green tea extract synergically inhibit inflammatory and catabolic mediator's synthesis by normal bovine and osteoarthritic human chondrocytes in monolayerFanny Comblain, Christelle Sanchez, Isabelle Lesponne, et al.Springerplus|March 23, 2013
Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runnersYves Henrotin, Alain Labasse, Thierry Franck, et al.Pain Medicine (Malden, Mass.)|February 1, 2011
Ecological or recalled assessments in chronic musculoskeletal pain? A comparative study of prospective and recalled pain assessments in low back pain and lower limb painful osteoarthritisSerge Perrot, Marc Marty, Valerie Legout, et al.The Journal of Biological Chemistry|October 25, 2007
Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expressionVirginie Lamour, Cédric Detry, Christelle Sanchez, et al.Frontiers in Medicine|April 20, 2023
Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping reviewMelanie Uebelhoer, Cécile Lambert, Juliane Grisart, et al.Pageof 13